180 related articles for article (PubMed ID: 24216759)
1. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.
Okur MN; Russo A; O'Bryan JP
Mol Cell Biol; 2014 Jan; 34(2):271-9. PubMed ID: 24216759
[TBL] [Abstract][Full Text] [Related]
2. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
[TBL] [Abstract][Full Text] [Related]
3. Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling.
Chandramouli S; Yu CY; Yusoff P; Lao DH; Leong HF; Mizuno K; Guy GR
J Biol Chem; 2008 Jan; 283(3):1679-1691. PubMed ID: 17974561
[TBL] [Abstract][Full Text] [Related]
4. αPIX Is a Trafficking Regulator that Balances Recycling and Degradation of the Epidermal Growth Factor Receptor.
Kortüm F; Harms FL; Hennighausen N; Rosenberger G
PLoS One; 2015; 10(7):e0132737. PubMed ID: 26177020
[TBL] [Abstract][Full Text] [Related]
5. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
[TBL] [Abstract][Full Text] [Related]
6. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
[TBL] [Abstract][Full Text] [Related]
7. Knockout of c-Cbl slows EGFR endocytic trafficking and enhances EGFR signaling despite incompletely blocking receptor ubiquitylation.
Crotchett BLM; Ceresa BP
Pharmacol Res Perspect; 2021 Apr; 9(2):e00756. PubMed ID: 33811466
[TBL] [Abstract][Full Text] [Related]
8. Cbl controls EGFR fate by regulating early endosome fusion.
Visser Smit GD; Place TL; Cole SL; Clausen KA; Vemuganti S; Zhang G; Koland JG; Lill NL
Sci Signal; 2009 Dec; 2(102):ra86. PubMed ID: 20029031
[TBL] [Abstract][Full Text] [Related]
9. Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts.
Lito P; Mets BD; Kleff S; O'Reilly S; Maher VM; McCormick JJ
J Biol Chem; 2008 Jan; 283(4):2002-9. PubMed ID: 18048363
[TBL] [Abstract][Full Text] [Related]
10. Intersectin 1 forms a complex with adaptor protein Ruk/CIN85 in vivo independently of epidermal growth factor stimulation.
Nikolaienko O; Skrypkina I; Tsyba L; Fedyshyn Y; Morderer D; Buchman V; de la Luna S; Drobot L; Rynditch A
Cell Signal; 2009 May; 21(5):753-9. PubMed ID: 19166927
[TBL] [Abstract][Full Text] [Related]
11. Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.
Wisniewski DJ; Liyasova MS; Korrapati S; Zhang X; Ratnayake S; Chen Q; Gilbert SF; Catalano A; Voeller D; Meerzaman D; Guha U; Porat-Shliom N; Annunziata CM; Lipkowitz S
J Biol Chem; 2023 Jan; 299(1):102766. PubMed ID: 36470425
[TBL] [Abstract][Full Text] [Related]
12. Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.
Odintsova E; van Niel G; Conjeaud H; Raposo G; Iwamoto R; Mekada E; Berditchevski F
J Biol Chem; 2013 Sep; 288(36):26323-26334. PubMed ID: 23897813
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
de Melker AA; van der Horst G; Borst J
J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819
[TBL] [Abstract][Full Text] [Related]
14. Antagonizing c-Cbl enhances EGFR-dependent corneal epithelial homeostasis.
Rush JS; Boeving MA; Berry WL; Ceresa BP
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4691-9. PubMed ID: 24985478
[TBL] [Abstract][Full Text] [Related]
15. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases.
Oved S; Mosesson Y; Zwang Y; Santonico E; Shtiegman K; Marmor MD; Kochupurakkal BS; Katz M; Lavi S; Cesareni G; Yarden Y
J Biol Chem; 2006 Aug; 281(31):21640-21651. PubMed ID: 16735510
[TBL] [Abstract][Full Text] [Related]
16. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.
Stern KA; Place TL; Lill NL
Biochem J; 2008 Mar; 410(3):585-94. PubMed ID: 18045238
[TBL] [Abstract][Full Text] [Related]
17. Cell surface epidermal growth factor receptors increase Src and c-Cbl activity and receptor ubiquitylation.
Parks EE; Ceresa BP
J Biol Chem; 2014 Sep; 289(37):25537-45. PubMed ID: 25074934
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation.
Lao DH; Yusoff P; Chandramouli S; Philp RJ; Fong CW; Jackson RA; Saw TY; Yu CY; Guy GR
J Biol Chem; 2007 Mar; 282(12):9117-26. PubMed ID: 17255109
[TBL] [Abstract][Full Text] [Related]
19. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration.
Duan L; Raja SM; Chen G; Virmani S; Williams SH; Clubb RJ; Mukhopadhyay C; Rainey MA; Ying G; Dimri M; Chen J; Reddi AL; Naramura M; Band V; Band H
J Biol Chem; 2011 Jan; 286(1):620-33. PubMed ID: 20940296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
